Together, these results show that high EBV seroprevalence and increased TGFβ1 serum levels in MIS-C and severe adult COVID-19 increase susceptibility to EBV reactivation, potentially affecting disease severity53. This evidence concerns the gene TGFB1 and COVID-19.